9
report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering 
;the market and can identify multiple cancers early and simultaneously.
+ Read More
article
Comments on Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products, Federal Register Docket FDA-2016-D-3561
Lauren K. Roth
Associate Commissioner for Policy
Food and Drug Administration
5630 Fishers Lane, Rm.
1061
Rockville, MD 20852
Dear Ms. Roth,
+ Read More
article
The 2024-2025 FasterCures LeadersLink Cohort
The 2024–2025 FasterCures’ LeadersLink program cohort has been carefully selected from a highly comp
etitive pool of candidates.
+ Read More
article
TRAIN Newsletter — April 2024
TRAIN eNews is delivered directly to organizations participating in The Research Acceleration and In
novation Network (TRAIN).
+ Read More
article
FasterCures Quarterly Update—April 2024
In This Newsletter
New FasterCures Team Member
Policy Updates
Events and Convenings Recap
FasterCur
es in the Community
+ Read More
article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
+ Read More
video
Building Impactful, Transparent, and Reciprocal Relationships with Industry Partners
How can patient organizations hoping to leverage the resources of industry researchers attract the
ir support and establish formal industry partnerships?
+ Read More